首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

2052510

喉糖市場：依產品類型、適應症、類型、通路和地區分類。

Throat Lozenges Market, By Product Type, By Indication, By Type, By Distribution Channel, By Geography

出版日期: 2026年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，潤喉糖市場規模將達到 51.7 億美元，到 2033 年將達到 78.8 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 6.2%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	51.7億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	6.20%	2033年市場規模預測：	78.8億美元

潤喉糖是含有藥物成分的糖果或藥片，旨在緩解喉嚨發炎和疼痛。感冒、咳嗽和其他咽喉感染疾病在各地日益普遍，推動了對潤喉糖的需求。人們健康意識的增強以及對速效非處方藥的偏好預計將促進市場成長。多種口味的潤喉糖能夠滿足不同消費者的喜好，這也是其受歡迎的原因之一。然而，其他治療方法的存在以及一些新興市場對潤喉糖認知度較低，可能會阻礙市場成長。

市場動態

全球潤喉糖市場正在成長，其主要驅動力是生活方式和氣候條件變化導致的咽喉感染疾病病例增加。都市區污染加劇，增加了居住者咽喉發炎的風險，而繁忙的日程和日益成長的壓力則削弱了免疫力。這導致人們越來越需要無需醫療干預即可快速緩解喉嚨問題，從而推動了潤喉糖的銷售。然而，過度服用潤喉糖的副作用以及喉嚨噴霧劑和漱口水等替代治療方法的存在，正在阻礙市場成長。各公司正在探索推出有機和草本產品的機會，以滿足注重健康的消費者的需求。專注於研發潤喉糖的新口味，可望為市場成長創造新的機會。

本研究的主要特點：

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數創建了全球潤喉糖市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務績效和策略。
本研究涵蓋的主要公司包括諾華製藥、西普拉製藥、寶潔公司、葛蘭素史克公司、賽諾菲公司、洛森製藥、Bliss GVS 製藥有限公司、Honibe公司、利口樂公司、Prestige Consumer Healthcare Inc.公司、Traditional Medicinals, Inc.公司、億萬國際公司、Inova Pharmaceuticals、Traditional Medicinals, Inc.公司、億萬國際公司、Inova Pharmaceuticals、強生集團服務公司、時強生集團服務公司、Inovaceuticals、強生集團服務公司。
本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品改進、市場擴張和行銷策略做出明智的決策。
全球潤喉糖市場包括該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析全球潤喉糖市場的策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Novartis AG
- Cipla
- Procter & Gamble
- GSK plc
- Sanofi
- Lozen Pharma
- Bliss GVS Pharma Ltd.
- Honibe
- Ricola
- Prestige Consumer Healthcare Inc.
- Traditional Medicinals, Inc
- MondelAz International
- Inova Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Reckitt Benckiser Group PLC

第10章分析師建議

機會分析
一致的機會地圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI6975

Throat Lozenges Market is estimated to be valued at USD 5.17 Bn in 2026 and is expected to reach USD 7.88 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 5.17 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.20%	2033 Value Projection:	USD 7.88 Bn

Throat lozenges are medicated candies or tablets that are intended to relieve throat irritation and soreness. Factors such as increasing prevalence of common cold, cough and other throat infections across regions boosts demand for throat lozenges. Rising health awareness and preference for over-the-counter medications for quick relief are expected to drive the market growth. The availability of throat lozenges in a wide range of flavors, catering to different consumer preferences, has boosted their popularity. However, alternative treatment options and lack of awareness in some emerging nations can hamper the market growth.

Market Dynamics:

Global throat lozenges market growth is driven by growing incidence of throat infections due to changing lifestyles and climatic conditions. Rising pollution levels in urban areas have increased the risk of throat irritation among city dwellers and busy schedules and higher stress levels have weakened immunity. This has boosted the need for fast relief from throat problems without medical intervention, thus, boosting sales of throat lozenges. However, factors such as side-effects of excessive lozenge intake and availability of alternative treatment in the form of throat sprays and gargles hampers the market growth. Companies are exploring opportunities to launch organic and herbal formulations to cater to health-conscious consumers. Focus on new flavors of these lozenges can offer new opportunities for the market growth.

Key Features of the Study:

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global throat lozenges market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Novartis AG, Cipla, Procter & Gamble, GSK plc, Sanofi, Lozen Pharma, Bliss GVS Pharma Ltd., Honibe, Ricola, Prestige Consumer Healthcare Inc., Traditional Medicinals, Inc, MondelA"z International, Inova Pharmaceuticals, Johnson & Johnson Services, Inc., Reckitt Benckiser Group PLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global throat lozenges market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global throat lozenges market.

Detailed Segmentation-

By Product Type (Revenue, USD Bn, 2021 - 2033)
Hard candy lozenges
Soft lozenges
Compressed lozenges
By Indication (Revenue, USD Bn, 2021 - 2033)
Sore throat
Cough and Cold
Throat diseases
By Type (Revenue, USD Bn, 2021 - 2033)
OTC
Prescription
By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
Novartis AG
Cipla
Procter & Gamble
GSK plc
Sanofi
Lozen Pharma
Bliss GVS Pharma Ltd.
Honibe
Ricola
Prestige Consumer Healthcare Inc.
Traditional Medicinals, Inc
MondelA"z International
Inova Pharmaceuticals
Johnson & Johnson Services, Inc.
Reckitt Benckiser Group PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Indication
- Market Snapshot, By Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Throat Lozenges Market, By Product Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hard candy lozenges
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Soft lozenges
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Compressed lozenges
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Throat Lozenges Market, By Indication, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Sore throat
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cough and Cold
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Throat diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Throat Lozenges Market, By Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
OTC
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Prescription
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Throat Lozenges Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Throat Lozenges Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cipla
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Procter & Gamble
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lozen Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bliss GVS Pharma Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Honibe
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ricola
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Prestige Consumer Healthcare Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Traditional Medicinals, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- MondelA"z International
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Inova Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Reckitt Benckiser Group PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies